-
Taxonomy & unit
-
ifrs-full: CHF
-
Summary
-
Addex Therapeutics Ltd. annual/quarterly Research And Development Expense history and growth rate from Q2 2021 to Q2 2023.
- Addex Therapeutics Ltd. Research And Development Expense for the quarter ending June 30, 2023 was ₣1.88M, a 67.4% decline year-over-year.
- Addex Therapeutics Ltd. annual Research And Development Expense for 2023 was ₣6.96M, a 52.5% decline from 2022.
- Addex Therapeutics Ltd. annual Research And Development Expense for 2022 was ₣14.7M, a 14.2% increase from 2021.
- Addex Therapeutics Ltd. annual Research And Development Expense for 2021 was ₣12.8M, a 23.8% increase from 2020.
Research And Development Expense, Quarterly (CHF)
Research And Development Expense, YoY Quarterly Growth (%)